Von Willebrand factor as a predictor of mortality in acute-on-chronic liver failure: Do not throw out the baby with the bathwaterLIVER INTERNATIONALIF5.22023-12-180OA
Patients with metabolic dysfunction-associated steatotic liver disease have preserved in vitro responses to antiplatelet drugsRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASISIF3.42023-10-010OAAI
Von Willebrand factor is an independent predictor of short-term mortality in acutely ill patients with cirrhosisLIVER INTERNATIONALIF5.22023-09-165OAAI
The international normalised ratio to monitor coagulation factor production during normothermic machine perfusion of human donor liversTHROMBOSIS RESEARCHIF3.42023-08-013OAAI
Prevalence of Bleeding and Thrombosis in Critically Ill Patients with Chronic Liver DiseaseTHROMBOSIS AND HAEMOSTASISIF4.32021-12-2822OA
Heparins have adequate ex vivo anticoagulant effects in hospitalized patients with cirrhosisJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52021-06-014OAAI
Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver diseaseJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52021-03-0130OAAI
Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgeryJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52020-11-019OAAI
Haemostatic Profiles are Similar across All Aetiologies of CirrhosisTHROMBOSIS AND HAEMOSTASISIF4.32019-01-0450OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向